Yuyu Pharma (CEO Robert Wonsang Yu, KRX 000220) and SD BIOSENSOR (CEO Hyo-Keun, Lee) entered into a Supply Agreement, where Yuyu Pharma will export COVID-19 Test Kits to the Global Market. Leveraging Yuyu Pharma's global network, the company is in talks with several healthcare providers and leading hospitals to export the COVID-19 kits.
US FDA gave Emergency Use Authorization (EUA) to STANDARD M nCoV Real-Time Detection Kit made by SD BIOSENSOR back in April 23, 2020. With the EUA, SD BIOSENSOR has the authority to supply STANDARD M nCoV Real-Time Detection Kit across the US. STANDARD M nCoV Real-Time Detection Kit is used for rapid identification and detection of novel coronavirus (2019-nCoV) nucleic acids in human nasopharyngeal swabs and throat swab samples. This is RT-PCR test that amplifies and diagnoses a specific gene sequence of COVID-19.
Federal Emergency Management Agency (FEMA), an agency within the US Department of Homeland Security, has already purchased $5.2 million USD of SD Biosensor's test kits back in April 2020.
Hyo-Keun, Lee CEO of SD BIOSENSOR said that "We have been providing quality kits since 2010. Our HIV, Malaria and Syphilis test kits are already on the World Health Organization (WHO) list of prequalified in vitro diagnostic products. And we are proud to know that our COVID-19 kits will help facilitate in the fight against the spread of the coronavirus and possibly save lives. We will continue to provide quality products to help improve the health of all people around the world"
Robert Yu, CEO of Yuyu Pharma, said that "The partnership with SD BIOSENSOR will help provide much needed COVID-19 Kits to medical professionals. We hope our efforts will contribute in the fight against the coronavirus."
About Yuyu Pharma
Yuyu Pharma (KRX: 000220) is a pharmaceutical company founded in 1941. The company manufactures, distributes, and does marketing for pharmaceutical products, medical devices, and medical foods in South Korea and Southeast Asia. Currently, Yuyu Pharma is focusing on developing new drugs for treating enlarged prostates and dry eye syndrome.
Yuyu pharma contact Point
Global Sales Team
Franklin Park / [email protected]
Photo - https://photos.prnasia.com/prnh/20200617/2833596-1-a
Caption - STANDARD(TM) M nCoV Real-Time Detection kit
Photo - https://photos.prnasia.com/prnh/20200617/2833596-1-b
Caption - Yuyu Pharma Will Export COVID-19 Test Kits to the Global Market
Bangchak Reaffirms Strong Financial Position with A+ TRIS Credit Rating for Second Consecutive Year
TRIS Rating Affirms "A+" Credit Rating for Bangchak Sriracha for Second Consecutive Year, Reinforcing Its Leadership in Thailand's Energy Sector
Power Buy under Central Retail Opens Its First Store in Krabi at Central Krabi Launching "Total Technology Hub" to Capture Southern Market Growth
PTTEP wins top honor for HR tech advancement at HR Excellence Awards Thailand 2025
Bangchak Announces Tender Offer for BSRC Securities at 6.50 BSRC Shares per 1 Newly Issued BCP Share, with the Tender Offer Period from 24 October to 27 November 2025
Mazda Announces Exhibition at JAPAN MOBILITY SHOW 2025 Exhibition Theme: "The joy of driving fuels a sustainable tomorrow"
KKP Asset Management Joins the UN-Supported Principles for Responsible Investment (PRI)
CP AXTRA Receives "The Best Sustaining Partner Award 2025" at the SOS Thailand Awards 2025
PTT is the First Company in Southeast Asia to Participate in J.P. Morgan's Investment Program Supporting Advanced Technologies for Cleaning up Plastic Waste in the River.